Journal article
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects
Abstract
Importance: The introduction of immune checkpoint inhibitor (ICI) therapy has improved cancer outcomes but at the cost of adverse events, mainly related to the immune system. Cardiovascular (CV) toxic effects, and especially myocarditis, are of particular concern and are the subject of this position statement by the International Cardio-Oncology Society with representation of experts from oncology, hematology, and cardiology.
Observations: CV …
Authors
Herrmann J; Barac A; Carver J; Cheng RK; Daniele A; Dent S; Deych E; Lee DH; Lenihan D; Leong DP
Journal
JAMA Oncology, Vol. 12, No. 1,
Publisher
American Medical Association (AMA)
Publication Date
November 13, 2025
DOI
10.1001/jamaoncol.2025.4543
ISSN
2374-2437